Sign in

You're signed outSign in or to get full access.

Alex P. Hamilton

Independent Director at ADDENTAX GROUP
Board

About Alex P. Hamilton

Alex P. Hamilton, 53, has served as an Independent Director of Addentax Group Corp. since May 10, 2021. He holds a B.A. in Economics from Brandeis University (1994) and is designated as the Board’s “audit committee financial expert.” His capital markets and investment banking background underpins his committee chair responsibilities and governance expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
CBD Biotech Inc.CFO and Director; previously Founder/CEOVarious since 2018/2019; prior CEO period not datedExecutive finance leadership experience
Hamilton StrategyFounder & CEOSince Nov 2014Strategic advisory leadership
Kei AdvisorsPresidentNov 2013–Nov 2014IR/advisory background
Donald Capital LLCCo-Founder; PresidentUndatedInvestment banking leadership
Craft Capital Management LLCManaging Director, Investment BankingCurrentOngoing capital markets role
Wunong Net Technology Co. (Nasdaq: WNW)Independent Director; Audit ChairDec 2020–Jul 2021Audit oversight; prior public board experience

External Roles

  • Current: Managing Director of investment banking at Craft Capital Management LLC .
  • Prior public company board: Wunong Net Technology (WNW), Independent Director and Audit Chair (Dec 2020–Jul 2021) .

Board Governance

  • Independence: Board affirmed Hamilton is independent under Nasdaq Rule 5605(a)(2) .
  • Committee assignments: Audit Committee Chair and Financial Expert; member of Compensation and Nominating & Corporate Governance Committees .
  • Meeting attendance:
    • Board: FY2024—1 meeting; all directors attended virtually .
    • Audit Committee: FY2024—5 meetings; all members present/participated .
    • Compensation Committee: FY2024—no meetings held .
    • Nominating & Corporate Governance Committee: FY2024—1 virtual meeting; full attendance .
  • Annual Meeting attendance: All five directors attended June 28, 2024 annual meeting virtually .
  • Executive sessions: Independent directors held regular executive sessions at most scheduled Board/committee meetings in FY2023 .

Board and committee meeting cadence

MetricFY 2023FY 2024
Board meetings (count)8; 100% attendance by all directors 1; all directors attended virtually
Audit Committee meetings (count)1 5; all members present/participated
Compensation Committee meetings (count)1 0
Nominating & Corporate Governance meetings (count)1 1

Shareholder advisory votes (context)

  • Say-on-Pay (Mar 31, 2025): Approved (For 2,018,686; Against 13,611; Abstain 247; 783,157 broker non-votes) .
  • Say-on-Pay frequency: Three years selected (Three Years 1,672,598; One Year 14,166; Two Years 805; Abstain 344,975; 783,157 broker non-votes) .

Fixed Compensation

Director compensation (cash retainer; no fees disclosed for chair/meetings)

MetricFY 2023FY 2024
Annual retainer (cash)$15,000 $15,000
Pay scheduleQuarterly in advance Quarterly in advance
Committee chair/member feesNot disclosed (none shown) Not disclosed (none shown)

Performance Compensation

  • Equity and options: None granted; no outstanding awards; no option exercises for directors .
  • Equity Incentive Plan: 2024 Plan approved; 1,345,000 shares reserved; directors eligible, but “to date” no grants have been made .
MetricFY 2023FY 2024
Stock Awards ($)$0 $0
Option Awards ($)$0 $0

Plan safeguards

  • Change-in-control: Plan provides immediate vesting of unvested portions unless otherwise specified; awards may be continued/assumed; potential cash-out per highest deal price less exercise price .
  • Clawback: Company-wide clawback policy adopted Oct 25, 2023 covering incentive compensation tied to financial reporting measures; recovery for three prior fiscal years upon restatement .
  • Hedging policy: Prohibits hedging/monetization transactions for officers/directors and designated insiders .

Other Directorships & Interlocks

Company/EntityRoleDatesPotential Interlock/Notes
Craft Capital Management LLCManaging Director, Investment BankingCurrentCapital raising role; no ATXG RPT disclosed involving Hamilton
Wunong Net Technology (WNW)Independent Director; Audit ChairDec 2020–Jul 2021Public company governance experience
CBD Biotech Inc.CFO and Director; prior Founder/CEOVarious since 2018/2019Executive finance role
Hamilton StrategyFounder & CEOSince Nov 2014Advisory firm
Donald Capital LLCCo-Founder; PresidentUndatedInvestment banking; no ATXG RPT disclosed involving Hamilton
Kei AdvisorsPresidentNov 2013–Nov 2014Advisory/IR background

Expertise & Qualifications

  • Audit/financial oversight: Designated Audit Committee Financial Expert; chairs Audit Committee .
  • Capital markets experience: Managing director (investment banking), prior investment banking and advisory leadership roles .
  • Education: B.A. Economics, Brandeis University (1994) .
  • Prior public company governance: WNW audit chair .

Equity Ownership

Beneficial ownership (as of record dates)

HolderShares Beneficially Owned% of Common Stock
Alex P. Hamilton
Alex P. Hamilton

Notes:

  • No vested/unvested equity; no outstanding awards; no exercises disclosed .
  • Anti-hedging policy in place; pledging guidelines not separately disclosed; plan references anti-hedging/pledging policy integration .

Governance Assessment

Positives

  • Independence and expertise: Hamilton is an independent director and Audit Committee Financial Expert; chairs Audit Committee, contributing to financial reporting integrity .
  • Audit Committee activity: Robust cadence in FY2024 (5 meetings) with full participation; formal charter aligned with Nasdaq standards .
  • Safeguards: Company has an anti-hedging policy and a clawback policy consistent with Section 10D, strengthening pay-for-performance accountability .
  • Shareholder support: Recent Say-on-Pay approval and triennial frequency indicate stable shareholder sentiment toward compensation practices .

Watch items / RED FLAGS

  • Ownership alignment: No reported share ownership for Hamilton; director pay entirely cash with no equity grants to date—limited “skin-in-the-game” alignment .
  • Compensation Committee inactivity: No Compensation Committee meetings in FY2024 could signal limited oversight cadence over executive/director pay despite ongoing governance needs .
  • Section 16 timeliness: Initial Form 3 filings for several insiders, including Hamilton, were reported late due to administrative oversight (FY2023 disclosure) .
  • Related-party environment (company-level): Multiple related-party balances and transactions involving executives/affiliates (e.g., loans, guarantees, rent-free arrangements); while none involve Hamilton, the overall RPT environment raises governance risk that requires strong independent oversight .

Potential Conflicts or Related-Party Exposure

  • Investment banking roles: Hamilton’s ongoing investment banking position (Craft Capital) and prior roles (Donald Capital) could present potential perceived conflicts if ATXG were to engage these firms; no related-party transactions are disclosed involving Hamilton .
  • No loans or payments: No transactions disclosed with entities controlled by Hamilton; RPTs listed involve other executives/affiliates .

Director Compensation Detail (reference table)

MetricFY 2023FY 2024
Salary/Retainer ($)$15,000 $15,000
Bonus ($)$0 $0
Stock Awards ($)$0 $0
Option Awards ($)$0 $0
All Other Compensation ($)$0 $0
Total ($)$15,000 $15,000

Policies Relevant to Investor Confidence

  • Anti-hedging: Prohibits hedging/monetization transactions for insiders .
  • Clawback: Restatement-based recovery for incentive compensation; applies to current/former executive officers and other designated senior employees .
  • Equity Incentive Plan: Approved in 2024; 1,345,000 shares reserved; directors eligible; change-in-control acceleration; no grants to date .

Summary Implications

  • Hamilton’s independent status, audit expertise, and active committee leadership are positives for board effectiveness. However, the lack of share ownership and absence of performance-tied director equity reduce alignment with long-term shareholder returns. The Compensation Committee’s inactivity in FY2024 warrants attention, particularly given the company’s broader related-party context that benefits from vigilant independent oversight .